Literature DB >> 10607109

The Ullanlinna Narcolepsy Scale: validation of a measure of symptoms in the narcoleptic syndrome.

.   

Abstract

The Ullanlinna Narcolepsy Scale (UNS) is a simple questionnaire-based method used to measure the symptoms of the narcoleptic syndrome. The 11-item scale (range 0-44) assesses the two main features of the narcoleptic syndrome, the abnormal sleeping tendency and cataplexy. The UNS sum score reliably distinguishes patients with the narcoleptic syndrome from patients with sleep apnoea, multiple sclerosis, and epilepsy. The mean score in patients with the narcoleptic syndrome was 27.3 (95% confidence limits 24.4-33.1); the sleep apnoea group with a mean score of 9.6 (95% confidence limits 7.2-12.0) came closest to this. Validation data were also selected from a large survey of non-institutionalized adults in Finland including groups with insomnia, excessive daytime sleepiness, sleep deprivation, sciatica, alcohol abuse, and high scores on a depression scale and on a scale of neurovegetative symptoms. With the lowest UNS score in the narcoleptic syndrome group (= 14) as the cutpoint, the sensitivity is 100% and the specificity is 98.8% in the subjects studied. The accurate assessment of the symptoms of the narcoleptic syndrome in a format suitable for questionnaire studies is essential.

Entities:  

Year:  1994        PMID: 10607109     DOI: 10.1111/j.1365-2869.1994.tb00104.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  20 in total

1.  Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study.

Authors:  Michel Lecendreux; Johanna Berthier; Jennifer Corny; Olivier Bourdon; Claire Dossier; Christophe Delclaux
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

Review 2.  [Moebius syndrome and narcolepsy].

Authors:  S Krämer; U Goldammer; E Sindern
Journal:  Nervenarzt       Date:  2014-12       Impact factor: 1.214

3.  Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns.

Authors:  Peter Bergman; Csaba Adori; Szilvia Vas; Ylva Kai-Larsen; Tomi Sarkanen; Andreas Cederlund; Birgitta Agerberth; Ilkka Julkunen; Beata Horvath; Diana Kostyalik; Lajos Kalmár; Gyorgy Bagdy; Anne Huutoniemi; Markku Partinen; Tomas Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-18       Impact factor: 11.205

Review 4.  Patient-Reported Measures of Narcolepsy: The Need for Better Assessment.

Authors:  Ulf Kallweit; Markus Schmidt; Claudio L Bassetti
Journal:  J Clin Sleep Med       Date:  2017-05-15       Impact factor: 4.062

5.  Parkinson's disease and insomnia.

Authors:  Ari Ylikoski; Kirsti Martikainen; Mariusz Sieminski; Markku Partinen
Journal:  Neurol Sci       Date:  2015-06-23       Impact factor: 3.307

6.  Environmental toxins and risk of narcolepsy among people with HLA DQB1*0602.

Authors:  Thanh G N Ton; W T Longstreth; Thomas D Koepsell
Journal:  Environ Res       Date:  2010-06-01       Impact factor: 6.498

7.  Does narcolepsy symptom severity vary according to HLA-DQB1*0602 allele status?

Authors:  Nathaniel F Watson; Thanh G N Ton; Thomas D Koepsell; Vivian H Gersuk; W T Longstreth
Journal:  Sleep       Date:  2010-01       Impact factor: 5.849

8.  Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.

Authors:  Rositsa Poryazova; Betina Schnepf; Esther Werth; Ramin Khatami; Ulrike Dydak; Dieter Meier; Peter Boesiger; Claudio L Bassetti
Journal:  Sleep       Date:  2009-05       Impact factor: 5.849

9.  Liability to anxiety and severe life events as predictors of new-onset sleep disturbances.

Authors:  Jussi Vahtera; Mika Kivimäki; Christer Hublin; Katariina Korkeila; Sakari Suominen; Tiina Paunio; Markku Koskenvuo
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

10.  Exercising before a nap benefits memory better than napping or exercising alone.

Authors:  Melodee Mograss; Monica Crosetta; Joanne Abi-Jaoude; Elizaveta Frolova; Edwin M Robertson; Veronique Pepin; Thien Thanh Dang-Vu
Journal:  Sleep       Date:  2020-09-14       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.